Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
出版年份 2020 全文链接
标题
Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
作者
关键词
-
出版物
Frontiers in Oncology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-05-15
DOI
10.3389/fonc.2020.00767
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hepcidin as a key iron regulator mediates glucotoxicity-induced pancreatic β-cell dysfunction
- (2019) Tingting Shu et al. Endocrine Connections
- Dihydroartemisinin, an antimalarial drug, induces absent in melanoma 2 inflammasome activation and autophagy in human hepatocellular carcinoma HepG2215 cells
- (2019) Xinli Shi et al. PHYTOTHERAPY RESEARCH
- miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
- (2019) Jian Xu et al. MOLECULAR THERAPY
- Relapsed refractory multiple myeloma: a comprehensive overview
- (2019) Abdul Hamid Bazarbachi et al. LEUKEMIA
- ROS signalling in the biology of cancer
- (2018) Jennifer N. Moloney et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Mitochondria: promising organelle targets for cancer diagnosis and treatment
- (2018) Xiao-Shuang Hou et al. Biomaterials Science
- An overview of the role of carfilzomib in the treatment of multiple myeloma
- (2017) Dimitrios C. Ziogas et al. EXPERT OPINION ON PHARMACOTHERAPY
- New development in CAR-T cell therapy
- (2017) Zhenguang Wang et al. Journal of Hematology & Oncology
- Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease
- (2017) Thomas A. Guerrero-Garcia et al. LEUKEMIA RESEARCH
- Protective effect of Salvianolic acid A on ischaemia-reperfusion acute kidney injury in rats through protecting against peritubular capillary endothelium damages
- (2017) Zuokai Zhang et al. PHYTOTHERAPY RESEARCH
- High glucose–induced ROS activates TRPM2 to trigger lysosomal membrane permeabilization and Zn2+-mediated mitochondrial fission
- (2017) Nada Abuarab et al. Science Signaling
- Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells
- (2017) Zheng-Hai Tang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Dihydroartemisinin treatment of multiple myeloma cells causes activation of c-Jun leading to cell apoptosis
- (2017) Yong Wang et al. Oncology Letters
- High glucose–induced ROS activates TRPM2 to trigger lysosomal membrane permeabilization and Zn2+-mediated mitochondrial fission
- (2017) Nada Abuarab et al. Science Signaling
- Evaluation of artemisinins for the treatment of acute myeloid leukemia
- (2016) Christina D. Drenberg et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells
- (2016) Renyu Lin et al. CANCER LETTERS
- Depolarization of mitochondrial membrane potential is the initial event in non-nucleoside reverse transcriptase inhibitor efavirenz induced cytotoxicity
- (2016) Krishna Kumar Ganta et al. CELL BIOLOGY AND TOXICOLOGY
- Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
- (2016) Nianhang Chen et al. CLINICAL PHARMACOKINETICS
- Ixazomib: First Global Approval
- (2016) Matt Shirley DRUGS
- Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Meletios A. Dimopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells
- (2015) Maria Lucibello et al. Oncotarget
- The Bcl-2 family: structures, interactions and targets for drug discovery
- (2014) Marc Kvansakul et al. APOPTOSIS
- Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway
- (2014) Junyan Chen et al. NEUROLOGICAL SCIENCES
- Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro
- (2012) HAITING MAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Caspase cleavage of cytochrome c1 disrupts mitochondrial function and enhances cytochrome c release
- (2011) Yushan Zhu et al. CELL RESEARCH
- Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart
- (2011) Hélène Lemieux et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
- (2011) Maria P. Crespo-Ortiz et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
- (2011) S K Kumar et al. LEUKEMIA
- Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
- (2010) Shuang-Jia Wang et al. CANCER LETTERS
- Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells
- (2010) Hao Chen et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- The Molecular Mechanism of Action of Artemisinin—The Debate Continues
- (2010) Paul M. O’Neill et al. MOLECULES
- Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro
- (2009) Hui-Jun Zhou et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action
- (2008) J. Hou et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search